Syringin( Eleutheroside B | NSC 287441 )

Catalog No. M10621 CAS No. 118-34-3

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

Syringin
Note

Research use only, not for human use.
Brief Description

Syringin has antitumour, antiproliferative, immunomodulatory and platelet aggregation inhibiting effects. Syringin can prevent Abeta(25-35)-induced neuronal cell damage.
Description

Syringin has antitumour, antiproliferative, immunomodulatory and platelet aggregation inhibiting effects. Syringin can prevent Abeta(25-35)-induced neuronal cell damage. It has anti-inflammatory and antinociceptive effects, may be attributed to its in vivo transformation to sinapyl alcohol.
In Vitro

——
In Vivo

——
Synonyms

Eleutheroside B | NSC 287441
Pathway

Immunology/Inflammation
Target

NOS
Recptor

NOS
Research Area

Other Indications
Indication

——

CAS Number

118-34-3
Formula Weight

372.4
Molecular Formula

C17H24O9
Purity

>98% (HPLC)
Solubility

Soluble in Pyridine, Methanol, Ethanol, etc.
SMILES

O[C@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)[C@@H]1OC2=C(OC)C=C(/C=C/CO)C=C2OC
Chemical Name

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-((E)-3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol

1. Cui Y, et al. Fundam Clin Pharmacol. 2015 Apr;29(2):178-84.

Calculator

molnova catalog